Hyman Paul
Department of Biology/Toxicology, Ashland University, 401 College Ave., Ashland, OH 44805, USA.
Pharmaceuticals (Basel). 2019 Mar 11;12(1):35. doi: 10.3390/ph12010035.
For a bacteriophage to be useful for phage therapy it must be both isolated from the environment and shown to have certain characteristics beyond just killing strains of the target bacterial pathogen. These include desirable characteristics such as a relatively broad host range and a lack of other characteristics such as carrying toxin genes and the ability to form a lysogen. While phages are commonly isolated first and subsequently characterized, it is possible to alter isolation procedures to bias the isolation toward phages with desirable characteristics. Some of these variations are regularly used by some groups while others have only been shown in a few publications. In this review I will describe (1) isolation procedures and variations that are designed to isolate phages with broader host ranges, (2) characterization procedures used to show that a phage may have utility in phage therapy, including some of the limits of such characterization, and (3) results of a survey and discussion with phage researchers in industry and academia on the practice of characterization of phages.
要使噬菌体可用于噬菌体疗法,它必须从环境中分离出来,并显示出除了能杀死目标细菌病原体菌株之外的某些特性。这些特性包括诸如相对较宽的宿主范围等理想特性,以及缺乏诸如携带毒素基因和形成溶原菌的能力等其他特性。虽然通常先分离噬菌体,然后再对其进行特性鉴定,但可以改变分离程序,使分离偏向于具有理想特性的噬菌体。其中一些变体被一些研究团队经常使用,而其他一些仅在少数出版物中有所展示。在这篇综述中,我将描述:(1)旨在分离具有更宽宿主范围的噬菌体的分离程序及变体;(2)用于表明噬菌体可能在噬菌体疗法中有用的特性鉴定程序,包括此类鉴定的一些局限性;(3)与工业界和学术界的噬菌体研究人员就噬菌体特性鉴定实践进行的一项调查结果及讨论。